Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Netherlands
  4. Euronext Amsterdam
  5. Royal DSM N.V.
  6. News
  7. Summary
    DSM   NL0000009827

ROYAL DSM N.V.

(DSM)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

DSM : launches award-winning protease enzyme range to do more with protein in food

05/15/2014 | 04:37am EDT

The Maxipro portfolio includes a wide range of proteases that help improve protein solubility, functionality and digestibility as well as improve the taste profile of protein and even reduce allergic reactions to certain proteins.

Marten Paasman, global marketing manager for DSM Food Specialties commented: "Proteins present in agricultural raw materials are not always ideal for use in particular food products or their production process. Here is where enzymes can add value, getting more out of less. DSM has a large variety of proteases that each cut the strings of amino acids present in proteins in different ways, delivering a particular functionality in the foods to which they are applied."

Breaking down long protein chains into smaller fragments, for example, helps improve the uptake of amino acids in the digestive tract, a functionality that is well appreciated by the sports nutrition market. Furthermore, allergic reactions to food products can be reduced by proteases that help degrade specific epitopes (immune response triggers) on wheat gluten or cow milk proteins. Also, high protein beverages typically require protein levels of 20% or more, putting a high demand on solubility of the protein used in the drink.

The market for high protein food products continues to grow as they enable consumers, conscious about health and wellness, to take a holistic approach to health and wellbeing that includes weight management, satiety and muscle build-up and repair for exercise.  Moreover, the awareness of protein intake has gone mainstream with a recent report* saying that over half of Americans are looking for more protein in their diet. Recent years have also seen an increase of prices of protein for multifunctional use.

Where and how specifically proteases cut amino acids and at which pH and temperature they do their work all impact how the protein will end up tasting and feeling in the end product. The DSM protease enzyme range is applicable for vegetable proteins like rice, pea, wheat and soy, and animal proteins such as whey and blood. As part of its launch, DSM is opening up a Maxipro testing program in which all those interested can participate and obtain protease samples for testing in their own specific application.

* Mintel, December 2013

distributed by

© Publicnow 2014
All news about ROYAL DSM N.V.
05/05ROYAL DSM N  : DSM lifts 2021 outlook as industrial materials demand recovers
RE
05/05ROYAL DSM N  : DSM Sales Climb in Q1 As Materials Segment Recovers
MT
05/05ROYAL DSM N  : DSM lifts 2021 outlook as demand for industrial materials recover..
RE
05/05ROYAL DSM N  : DSM provides Q1 2021 trading update
PU
04/29ROYAL DSM N  : DSM Cancels 6.6 Million Shares to Complete Capital Reduction
MT
04/29ROYAL DSM N  : DSM announces cancellation of 6.6m treasury shares to conclude re..
PU
04/13Forget about meat, France's Avril to focus on plants
RE
04/05ROYAL DSM N  : Health tech company Hologram Sciences launches personalized healt..
PU
04/01ROYAL DSM N  : Completes Sale Of Resins & Functional Materials Segment To Covest..
MT
04/01ROYAL DSM N  : DSM completes sale of Resins & Functional Materials businesses
PU
More news
Financials
Sales 2021 8 733 M 10 515 M 10 515 M
Net income 2021 912 M 1 098 M 1 098 M
Net Debt 2021 1 170 M 1 409 M 1 409 M
P/E ratio 2021 27,3x
Yield 2021 1,67%
Capitalization 26 410 M 31 697 M 31 798 M
EV / Sales 2021 3,16x
EV / Sales 2022 2,95x
Nbr of Employees 21 313
Free-Float 94,7%
Chart ROYAL DSM N.V.
Duration : Period :
Royal DSM N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ROYAL DSM N.V.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 153,58 €
Last Close Price 153,35 €
Spread / Highest target 17,4%
Spread / Average Target 0,15%
Spread / Lowest Target -49,1%
EPS Revisions
Managers and Directors
NameTitle
Dimitri de Vreeze Co-Chief Executive Officer & COO
Géraldine Matchett Co-Chief Executive Officer & CFO
Robert John Routs Chairman-Supervisory Board
Pauline F. M. van der Meer Mohr Deputy Chairman
Eileen A. Kennedy Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
ROYAL DSM N.V.8.91%31 697
BASF SE7.17%76 459
SHIN-ETSU CHEMICAL CO., LTD.2.27%70 168
DUPONT DE NEMOURS, INC.13.80%43 061
EVONIK INDUSTRIES AG11.32%16 611
FMC CORPORATION3.58%15 778